The British pharmaceutical giant is working with the U.K. Dementia Research Institute to exploit a “natural randomization” ...

GSK said on Tuesday that it is studying a group of more than a million older adults in the UK to examine whether its ...

After multiple studies have suggested a link between its shingles vaccine and dementia prevention, GSK is taking advantage of ...

Getting the Shingrix vaccine after the age of 50 can reduce your chances of developing the painful skin condition known as ...

The recombinant zoster vaccine is effective in preventing herpes zoster in adults aged 50 years or older with rheumatoid ...

The study will analyse electronic health records of 65- and 66-year olds from the UK’s National Health Service (NHS).

Curevo, a Seattle-based biotech startup developing a vaccine against shingles, raised $110 million in a Series B ...

DEAR DR. ROACH: I am a 79-year-old woman who received the original Zostavax vaccine around 2010. Then, when the newer, improved Shingrix vaccine became available, I was given the two-shot series ...

I do not remember if I got chickenpox when I was young. S.R.E. Two doses are all you need for the Shingrix vaccine, which is the vaccine given to people who have either had chickenpox or the ...

Then I remembered that I could easily schedule the vaccine through the website scheduler.” What is SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted)? SHINGRIX is an FDA-approved vaccine for the ...

Vaccination with GSK's recombinant shingles vaccine, Shingrix, could delay the onset of dementia, according to researchers in the UK. A study published in Nature Medicine suggests that people ...

GSK is enlisting the aid of China’s Chongqing Zhifei Biological Products (Zhifei) to drive sales of its most important vaccine, Shingrix, in China over the next few years, and may also call upon ...